Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Orillia7

T.SW

RE:sw.to deal with intel

What are they talking about?

April 7, 2014

ISYRF

RE:RE:Good week

Why would you think insiders can purchase shares now? Their Q1 just ended...

April 5, 2014

ISYRF

RE:RE:RE:RE:Great time ahead!

lots of things to be critical of, however get your facts straight. The value...

March 31, 2014

ISYRF

RE:RE:the only thing that makes sense is...

wishful thinking. There are probably 100 companies that can do what Intrinsyc...

March 30, 2014

ISYRF

RE:Nice Volume today

that looks legit. I liked the response. You have to admit he put his own...

March 25, 2014

ISYRF

RE:Quiet

I don't expect too much. The deals they have announced are for Q2 or...

March 19, 2014

ISYRF

RE:RE:RE:RE:Intrinsyc Announces Order for Machine-to-Machine

I agree with that. Build products, get orders, show financial results...

March 11, 2014

ISYRF

RE:RE:Intrinsyc Announces Order for Machine-to-Machine

Marketing their products and getting orders is what they should be focused on...

March 10, 2014

ISYRF

RE:RE:Intrinsyc Announces Order for Machine-to-Machine

"there are no bids!!!!" share price up 11% today. so you are wrong...

March 10, 2014

ISYRF

RE:RE:RE:The Market will make Intrinsyc Go

Sell your shares and then there will be some activity. I'm sure someone...

March 3, 2014

ISYRF

RE:RE:New Videos

Its probably a waste of time responding because all of your comments are...

February 27, 2014

ISYRF

RE:RE:RE:from the CES 2014

I think your analysis is right. They seem to have lots of projects in early...

February 11, 2014

ISYRF

RE:from the CES 2014

The QNX job post makes sense if it has something to do with this. It does...

February 11, 2014

ISYRF

RE:RE:RE:RE:RE:Intrinsyc Ahead of time.

Derek's mom: This is the results for the two years prior to current...

February 6, 2014

ISYRF

RE:RE:RE:Intrinsyc Ahead of time.

Now your moronic comments make sense. You must be Derek's mom. Intrinsyc...

February 6, 2014

ISYRF

another great video

https://www.youtube.com/watch?v=-Ojgr14FtBo

February 2, 2014

ISYRF

RE:where's the capital?

Until the last couple of months, Intrinsyc was just a very good engineering...

January 29, 2014

ISYRF

Increasing Design Wins and Interest in Intrinsyc's OpenQ

From the PR this morning… “Intrinsyc’s Open-Q 8074 SOM is an ideal fit for...

January 29, 2014

ISYRF

What this means....

Myth Innovations looks like a startup shipping their first product so I'm...

January 25, 2014

ISYRF

RE:RE:RE:drip, drip, drip....

I checked out your complaint.  I called the company, entered the CEO'...

January 23, 2014

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next

Featured Company

Theralase Technologies Inc.

Theralase Technologies Inc. V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ... view more »